PRNAF Earnings
Alterity Therapeutics Limited
1W: +0.0%
1M: +0.0%
3M: +627.3%
YTD: +6249.2%
1Y: +13233.3%
3Y: +7447.2%
5Y: +1631.6%
$0.40
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Last Earnings
2026-08-28
EPS
A$-0.00 (US$-0.00)
▲ Beat +59.8%
Revenue
$2M
Est (actual pending)
Estimate vs Actual
Earnings Surprise History
7/20
EPS Beats
4/20
Revenue Beats
35%
EPS Beat Rate
20%
Rev Beat Rate
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | annual | 2027-06-30 | A$-0.02 | A$-0.02 | — | A$1,497,801 | A$1,493,725 |
| 2026-10-02 | annual | 2031-06-30 | A$0.00 | A$0.00 | — | A$66,110,664 | A$65,930,757 |
| 2026-10-02 | annual | 2030-06-30 | A$-0.02 | A$-0.02 | — | A$13,234,773 | A$13,198,757 |
| 2026-10-02 | annual | 2029-06-30 | A$-0.03 | A$-0.03 | — | A$4,785,011 | A$4,771,990 |
| 2026-10-02 | annual | 2028-06-30 | A$-0.03 | A$-0.03 | — | A$3,381,270 | A$3,372,069 |
| 2026-10-01 | annual | 2031-06-30 | A$0.00 | A$0.00 | — | A$66,794,121 | A$66,110,664 |
| 2026-10-01 | annual | 2030-06-30 | A$-0.02 | A$-0.02 | — | A$13,371,595 | A$13,234,773 |
| 2026-10-01 | annual | 2028-06-30 | A$-0.03 | A$-0.03 | — | A$3,416,226 | A$3,381,270 |
| 2026-10-01 | annual | 2027-06-30 | A$-0.02 | A$-0.02 | — | A$1,513,286 | A$1,497,801 |
| 2026-10-01 | annual | 2029-06-30 | A$-0.03 | A$-0.03 | — | A$4,834,479 | A$4,785,011 |
| 2026-09-29 | annual | 2028-06-30 | A$-0.03 | A$-0.03 | — | A$3,419,147 | A$3,416,226 |
| 2026-09-29 | annual | 2027-06-30 | A$-0.02 | A$-0.02 | — | A$1,514,580 | A$1,513,286 |
| 2026-09-29 | annual | 2029-06-30 | A$-0.03 | A$-0.03 | — | A$4,838,613 | A$4,834,479 |
| 2026-09-29 | annual | 2031-06-30 | A$0.00 | A$0.00 | — | A$66,851,234 | A$66,794,121 |
| 2026-09-29 | annual | 2030-06-30 | A$-0.02 | A$-0.02 | — | A$13,383,028 | A$13,371,595 |
Earnings Call Transcripts
No transcripts available.